Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Deferred Revenue (2016 - 2026)

Cryo Cell International's Current Deferred Revenue history spans 17 years, with the latest figure at $9.4 million for Q1 2026.

  • Quarterly results put Current Deferred Revenue at $9.4 million for Q1 2026, down 83.63% from a year ago — trailing twelve months through Feb 2026 was $9.4 million (down 83.63% YoY), and the annual figure for FY2025 was $9.7 million, down 82.73%.
  • Current Deferred Revenue for Q1 2026 was $9.4 million at Cryo Cell International, down from $9.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $57.2 million in Q1 2025 to a low of $9.4 million in Q1 2026.
  • The 5-year median for Current Deferred Revenue is $46.5 million (2023), against an average of $40.1 million.
  • The sharpest move saw Current Deferred Revenue rose 12.84% in 2023, then crashed 83.63% in 2026.
  • Year by year, Current Deferred Revenue stood at $45.6 million in 2022, then increased by 11.64% to $50.9 million in 2023, then increased by 10.72% to $56.3 million in 2024, then crashed by 82.73% to $9.7 million in 2025, then decreased by 3.83% to $9.4 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $9.4 million, $9.7 million, and $9.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.